Reaction

Viral Load Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,854 reports · 43 co-occurring drugs

As of the last recalculation, Viral Load Increased appears in 3,854 FAERS reports alongside 43 co-occurring drug terms. The strongest observed disproportionality signal is CABOTEGRAVIR (PRR 327.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cabotegravir	434	327.0	345.6
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	281	90.3	91.7
Entecavir	127	60.7	61.4
Tenofovir Disoproxil Fumarate Tablets	89	57.0	57.5
Dolutegravir Sodium	84	51.4	51.9
Ritonavir 100 Mg	129	48.2	48.6
Lamivudine Oral	211	47.6	48.0
Darunavir	127	46.9	47.3
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	85	46.6	47.0
Lamivudine	233	43.3	43.6
Atazanavir	110	42.5	42.8
Peginterferon Alfa-2A	378	41.8	42.0
Raltegravir	119	40.1	40.4
Tenofovir Disoproxil Fumarate	223	38.6	38.9
Ritonavir	196	38.1	38.4
Nevirapine	61	37.1	37.3
Lopinavir And Ritonavir	88	35.9	36.1
Ribavirin	381	35.4	35.6
Efavirenz	69	34.0	34.2
Sofosbuvir	120	33.9	34.1
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	51	31.0	31.2
Abacavir Sulfate	55	30.9	31.1
Zidovudine	73	30.0	30.2
Ganciclovir Sodium	54	27.9	28.1
Ganciclovir	50	26.7	26.8
Valganciclovir Hydrochloride Powder,	55	24.7	24.8
Valganciclovir	81	23.7	23.8
Valganciclovir Hydrochloride	81	23.7	23.8
Glecaprevir And Pibrentasvir	46	22.9	23.0
Emtricitabine And Tenofovir Disoproxil Fumarate	176	21.8	21.9
Emtricitabine And Tenofovir Alafenamide	35	16.8	16.9
Velpatasvir And Sofosbuvir	24	10.2	10.2
Oseltamivir	8	5.4	5.4
Ledipasvir And Sofosbuvir	16	4.5	4.5
Daspone	7	3.9	3.9
Dapsone Gel, 5%	7	3.9	3.9
Tacrolimus Ointment 0.1%	87	3.8	3.8
Tacrolimus Extended-Release Capsules	87	3.8	3.8
Erythropoietin	14	3.7	3.7
Tacrolimus	103	3.6	3.6
Bendamustine Hcl	10	3.5	3.5
Thiotepa	6	3.4	3.4
Anakinra	10	3.3	3.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.